Member Info for Tiger16

5085 , excellent post .. well done , you are far the leader in the pack here , would you mind if I asked how much have invested here ?

i actually agree with affrm for the first time , this is a company with some serious assets and a deal completed according to transformational rns ..

now we have the same leader in the pack , leading us as ceo , not rocket science to work out the deal with now be completed tp benefit both parties ..

now why such a delay in the accounts being audited , well i am afraid we do live in a corrupt world , hence if the business asks the auditors to delay , they will .. simple as that .. the million dolor questions is why , again , either hiding the true value of assets for a complete take over .. or recovering funds so no one is incriminated ..

we all know it does not take months to audit a company of this size .. please ... a basic ignorance of are intel ..

i have said this before , and i will say it again , no bull **** , if the new ceo stays , which so far so good , and their is no sudden resignation , then this will come back and make us life changing money , depending on how much you have invested here .

should the new ceo resign then this is 100 per cent going to be manipulated and de listed never to return again ..

now the ceo has not resigned nor has he given any indication of what do expect next or what has been resolved or not been resolved ...

this corner stone share holder wasnt just mentioned for a laugh or give us a carrot .. why , we are not trading .. no there is a angle to this non disclosure of corner stone investor.. who is this party ?

no doubt we have all had our fare share of stress and played the waiting game here ., with our funds stuck .. hence its been hard work .. hence karma will kick in and we will all be rewarded is my belief .. i hope ..

USA open now , and the share price ticking up .. watch this space , someone knows something ..

Cont; offer promising therapeutics solutions for diseases with high unmet needs suggesting a favorable outlook for investors ..

Disclaimer ; this report is for informational purposes only and does not constitute investment advice . Potential investors should conduct their own due diligence and if need be a financial advisor ..

**Analyst Report: ImmuPharma PLC (LSE: IMM)**

**Executive Summary**

mmuPharma PLC is at the forefront of peptide-based therapeutic innovation, targeting diseases with significant unmet medical needs.he company's lead compound, P140, has demonstrated promising immunomodulatory effects in autoimmune pathologies, positioning it as a potential game-changer in the treatment landscape.ith a robust pipeline and strategic leadership, ImmuPharma is poised for substantial growth.

**Scientific Rationale for Investment**

1. **P140 Peptide Mechanism of Action**

140, a 21-mer peptide, exhibits a unique mechanism by modulating autophagy pathways, specifically by interacting with HSPA8 (Hsc70).his interaction leads to the downregulation of MHC class II molecule expression on antigen-presenting cells, thereby reducing autoreactive T-cell activation.uch a targeted approach addresses the underlying immunopathogenesis of systemic lupus erythematosus (SLE) without broad immunosuppression.

2. **Clinical Development in SLE**

upuzor™, the proprietary formulation of P140, has progressed to Phase III clinical trials for SLE.revious studies have indicated its ability to significantly reduce disease activity, as measured by the SLE Disease Activity Index (SLEDAI), with a favorable safety profile.he absence of severe adverse events commonly associated with current SLE therapies underscores its potential as a first-line treatment.

3. **Expansion into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)**

uilding on the immunomodulatory properties of P140, ImmuPharma is exploring its application in CIDP.reclinical models have shown that P140 can modulate peripheral nerve inflammation by attenuating macrophage and T-cell infiltration, suggesting a promising therapeutic avenue for this debilitating condition.

4. **Innovative Peptide Platform**

eyond P140, ImmuPharma's peptide platform leverages proprietary technologies to enhance peptide stability, bioavailability, and target specificity.his platform has the potential to generate a pipeline of novel therapeutics addressing various autoimmune and inflammatory diseases, thereby broadening the company's market reach.

**Leadership and Strategic Vision**

r. Sébastien R. Goudreau, Chief Executive Officer of ImmuPharma Biotech, has been instrumental in advancing the company's research initiatives.is expertise in medicinal chemistry and pharmacology has been pivotal in optimizing the peptide development process.ollaborating with Dr. Tim Franklin, Chief Operating Officer, their combined leadership ensures a strategic focus on both scientific innovation and operational excellence.

**Conclusion**

mmuPharma's dedication to pioneering peptide-based therapies, coupled with its strategic leadership and innovative platform, positions the company for significant advancements in the biopharmaceutical sector.he scientific underpinnings of its pipeline, particularly the P140 peptide, offer promisi

Cont : possibly influenced by policies from the previous administration, gearing up for a bidding war over Rockfire's invaluable assets. While we can't confirm these rumors, the mere speculation underscores the immense value and potential others see in Rockfire.

Conclusion:

In the high-stakes world of mining exploration, Rockfire Resources stands out as a shining star. With a diversified and rich asset base, strategic acquisitions, and market dynamics tilting in their favor, the company is poised for extraordinary growth. For those looking to invest in a company with solid fundamentals and a trajectory aimed straight for the stratosphere, Rockfire Resources is the name to remember.

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions.

Ladies and gentlemen, gather 'round, because today we're diving into an opportunity that's hotter than a two-dollar pistol! I'm talking about Rockfire Resources PLC (LSE: ROCK), a company that's not just sitting on a goldmine—they're sitting on a treasure trove of precious and base metals, and they're poised to skyrocket!

A Portfolio That's Pure Gold (and Zinc, and Copper...):

Rockfire isn't your run-of-the-mill exploration company. They've strategically positioned themselves with assets that are the envy of the industry:

Molaoi Project in Greece: This isn't just any zinc deposit; it's a volcanogenic massive sulfide deposit teeming with zinc, lead, silver, and even germanium. The potential here is staggering, with mineralization starting right at the surface and remaining open at depth. We're talking about a project that could redefine the company's future.

MARKETS.INVESTORSCHRONICLE.MARKITDIGITAL.COM

Lighthouse Gold Project in Australia: With over 208,000 ounces of gold and 1.5 million ounces of silver, this project is a shining beacon of profitability. The gold grades are impressive, and the exploration upside is immense.

ROCKFIRERESOURCES.COM

Copperhead and Copper Dome Projects: These aren't just names; they're indicative of the vast copper potential Rockfire holds. With a JORC Inferred Resource of 64 million tonnes at 0.19% copper equivalent, Copperhead alone boasts 120,000 tonnes of copper equivalent. In a world where copper demand is soaring, this is music to any investor's ears.

ROCKFIRERESOURCES.COM

Strategic Acquisitions:

But wait, there's more! Rockfire isn't just sitting back; they're aggressively expanding. In a transformative move, they've acquired 100% of Emirates Gold DMCC and 99% of Emperesse Bullion LLC. This isn't just a step—it's a leap into the big leagues, positioning Rockfire as a major player in the precious metals refining and trading arena.

MARKETSCREENER.COM

Market Dynamics Favoring Rockfire:

Now, let's talk macroeconomics. The recent trade tensions have only amplified the strategic importance of critical minerals. The United States, aiming to maintain its superpower status, is in dire need of zinc and rare earth elements for defense and technology sectors. Rockfire's asset portfolio aligns perfectly with this demand, making them a potential key supplier in a market hungry for these resources.

Leadership with Skin in the Game:

And here's the kicker—the directors of Rockfire are major shareholders. They're not just steering the ship; they've got their own treasure on board, ensuring their interests are perfectly aligned with shareholders. This kind of commitment is rarer than a unicorn in a haystack.

Rumors of a Lucrative Buyout:

Now, while we tread carefully here, the grapevine is buzzing with whispers that Melton, a billion-dollar mining juggernaut set to IPO in the second quarter, has its eyes on Rockfire. And that's not all—there's chatter about a U.S. corporation

The rumor in the city is that the deal between Metlen and Rock would have to be completed in the next couple of days , if they are seeking to list in London with accounts audited to include Rock assets and their value which would be better posed if Melton take over now , and get their logistics to conclude the find of raw minerals ..

This is really now looking to blow big time making life changing money for those who get in now or have already ..

just woh , woh ...

What is the point of that short video ??

This is what I dont quite get , this is no doubt one of the most safest bets anyone can make right now in reference to buying on Aim ..

A NO PLACING REQUIRED , ONE MILLIONS USD IN THE BANK

B CHINA AND USA TRADE WAR JUST GOT BIGGER THAN EVER TODAY , AS CHINA REACTS .

C MELTON BILLION DOLOR WORTH COMPANY , ABOUT TO LIST IN LONDON , THEY NEED ROCK RESOURCES TO ENSURE NO ONE ELSE ENTERS THEIR JURISDICTION .ROCK OWNS THE RIGHTS , AND IN EUROPE , NOT AFRICA ..

THE MARKET SEEMS AS IF IT NEEDS SOME FORM OF CONFIRMATION THAT THE MINERALS ARE ECONOMICAL .. THEY ARE , HISTORY OF GREECE PROVES THIS IF ONE DOES THEIR RESEARCH ..

THE SP IS WAY TO LOW , SO UNDERVALUED ..

Its been confirmed to me just now by certain auditors working in the City , that no way does it take until the end of april to audit accounts for PPP , something is going on in the background , either a complete buy out or getting the funds , the missing funds in the bank before this comes into the public arena ....

Trump dosnt need to worry about the next place to go for his raw minerals , he has Eton Mask already on it ...

Anyone who sell their golden tickets here , will regret their decision for the rest of their life time is my opinion , based on solid research of the asset and Melton positioned nicely to take over ,..

St martins excellent posts , and I agree 4 p would be a realistic value base line ... def wont be anything less .. could be alote more if the market all jump in at once ...

There i a strong rumor a deal is in the making , and hints have been dropped by our CEO in two interviews already to date .. What we have is ground breaking and significant , hence why would a Big Pharma wait around to buy a late asset with there logistics in place already to ensure a straight direct route to the market .,.. This is the time to buy , before the a price war begins as the asset matures in confirmations of proof ...

ANY TIME NOW .. ANY TIME NOW ..

The next news here will be he results and the Melton bid for the assets Rock holds ....worth billions just like he value of Melton

Totally agree share bell , they have proved they have the minerals , they have a million pound in the bank and are drilling now for JOK report to confirm what they have already confirmed , if the results are even higher and more clear .. OMG .. Trade war , USA now needs Europe , more so Greece , how long will it take for this to be bought out , and drilled by Giant .. Melton must have their eyes on this , as they about to list....

The trade war between China and the USA have spooked the markets significantly .. Trump has raised Tariffs on china , canada and Mexico , USD is up as well as OIL , these raw minerals are required now , all stocks are down right now inc SP500 , hence stocks like this and oil stocks as well as bio tech are safe bets ..

These minerals will now go up even higher in price as China will def not be selling to the USA or any of its trade partners .. I would love to top up now here , but have ready gone is very high ..

PPP is looking even more attractive once it returns , situated in Texas and oil prices looking to hit the roof .. we need this back asap ...

I was thinking out loud , so please do contribute anyone , as one would now think that if they was going to do a placing it would of been activated by now , and if my memory serves me correctly then if they do need cash now the warrants can be brought into play .. ???

Rob 50 , 20 p a share is ripping us all of as it is worth a hell of alote more .. Lunn and the CEO know this .. I believe the duck have all been set up for a complete take over , the accounts delay is to ensure we as share holders walk away without anything being made public and criminal .. very low ball offer , yet when they make this look really bad , they can choose the price .

Or the above speculations are incorrect and the corner stone investor along with robert save the day and take this to a whole new level ..

The worst case for us now is the CEO resigning ... he hasnt as yet after the RNS , so that means he is aware of everything in reference to accounts .. so as long as he is there we have a fighting chance ... and a big one ...